Earnings call Dr. Lal PathLabs reported Q3 FY26 revenue of ₹660 crore, up 10.6% YoY, driven by favorable test and geography mix. EBITDA margin (pre-exceptional) improved to 27.2% despite a ₹30 crore ...
Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results